Konica Minolta Precision Medicine: Aaron Elliott, Tom Schoenherr

Aaron Elliott has been name CEO of Konica Minolta Precision Medicine. He is currently the CEO of Ambry Genetics. In his new role, he will be responsible for all KMPM business units, which include Ambry Genetics, Invicro, and KMPM-Japan. Previously, Elliott served as chief operating officer and CSO of Ambry Genetics.

Tom Schoenherr has been promoted to CEO of Ambry Genetics. He joined the company in 2017 as chief commercial officer.